Adverse Reactions to Drugs: Diagnosis and Management
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 40
Special Issue Editor
Interests: clinical pharmacology; drug safety; adverse drug events; adverse drug reactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the diagnosis and management of adverse drug reactions (ADRs), a critical aspect of patient safety in healthcare. ADRs, ranging from mild to life-threatening, pose significant challenges to clinicians in terms of recognition, evaluation, and treatment. The articles in this Special Issue delve into the latest diagnostic techniques, including the use of biomarkers, clinical algorithms, and pharmacogenomic testing, to enhance the detection of ADRs. The management strategies discussed emphasize the importance of a multidisciplinary approach involving pharmacists, physicians, and nurses to ensure timely intervention and prevention of ADRs. Furthermore, this Special Issue explores the role of education and training in enhancing the awareness and skills of healthcare professionals in managing ADRs, ultimately leading to improved patient outcomes and safety.
Dr. Elena Ramírez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adverse drug reactions
- serious adverse drug reactions
- unexpected adverse drug reactions
- adverse drug events
- drug-related side effects
- drug safety
- causality assessment of adverse drug reactions
- diagnostic biomarker
- non-immediate drug hypersensitivity reactions
- immediate drug hypersensitivity reactions
- pharmacogenetics
- in vivo tests
- in vitro tests
